AAAAAA

   
Results: 1-23 |
Results: 23

Authors: Celis, H Thijs, L Staessen, JA Birkenhager, WH Bulpitt, CJ de Leeuw, PW Leonetti, G Nachev, C Tuomilehto, J Fagard, RH
Citation: H. Celis et al., Interaction between nonsteroidal anti-inflammatory drug intake and calcium-channel blocker-based antihypertensive treatment in the Syst-Eur trial, J HUM HYPER, 15(9), 2001, pp. 613-618

Authors: de Leeuw, PW Birkenhager, WH
Citation: Pw. De Leeuw et Wh. Birkenhager, The elderly hypertensive; Cardiovascular and neurohormonal profile, CARDIO DRUG, 15(3), 2001, pp. 263-267

Authors: Wang, JG Staessen, JA Tizzoni, L Brand, E Birkenhager, WH Fagard, R Herrmann, SM Bianchi, G
Citation: Jg. Wang et al., Renal function in relation to three candidate genes, AM J KIDNEY, 38(6), 2001, pp. 1158-1168

Authors: Staessen, JA Wang, JG Brand, E Barlassina, C Birkenhager, WH Herrmann, SM Fagard, R Tizzoni, L Bianchi, G
Citation: Ja. Staessen et al., Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population, J HYPERTENS, 19(8), 2001, pp. 1349-1358

Authors: Voyaki, SM Staessen, JA Thijs, L Wang, JG Efstratopoulos, AD Birkenhager, WH de Leeuw, PW Leonetti, G Nachev, C Rodicio, JL Tuomilehto, J Fagard, R
Citation: Sm. Voyaki et al., Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension, J HYPERTENS, 19(3), 2001, pp. 511-519

Authors: Staessen, JA Wang, JG Brand, E Barlassina, C Birkenhager, WH Herrmann, SM Fagard, R Tizzoni, L Bianchi, G
Citation: Ja. Staessen et al., Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. (vol 19, pg 1349, 2001), J HYPERTENS, 19(10), 2001, pp. 1921-1921

Authors: Wang, JG Staessen, JA Fagard, RH Birkenhager, WH Gong, LS Liu, LS
Citation: Jg. Wang et al., Prognostic significance of serum creatinine and uric acid in older Chinesepatients with isolated systolic hypertension, HYPERTENSIO, 37(4), 2001, pp. 1069-1074

Authors: Birkenhager, WH Wang, JG Staessen, JA
Citation: Wh. Birkenhager et al., Dementia and statins, LANCET, 357(9259), 2001, pp. 880-880

Authors: Birkenhager, WH Forette, F Seux, ML Wang, JG Staessen, JA
Citation: Wh. Birkenhager et al., Blood pressure, cognitive functions, and prevention of dementias in older patients with hypertension, ARCH IN MED, 161(2), 2001, pp. 152-156

Authors: Forette, F Rigaud, AS Seux, ML Staessen, JA Thijs, L Birkenhager, WH
Citation: F. Forette et al., Reduction of dementia by calcium-antagonist-based antihypertensive treatment, EUR H J SUP, 2(D), 2000, pp. D17-D19

Authors: Birkenhager, WH Staessen, JA Gasowski, J de Leeuw, PW
Citation: Wh. Birkenhager et al., Effects of antihypertensive treatment on endpoints in the diabetic patients randomized in the systolic hypertension in Europe (Syst-Eur) trial, J NEPHROL, 13(3), 2000, pp. 232-237

Authors: Rigaud, AS Seux, ML Staessen, JA Birkenhager, WH Forette, F
Citation: As. Rigaud et al., Cerebral complications of hypertension, J HUM HYPER, 14(10-11), 2000, pp. 605-616

Authors: Robertson, JIS Birkenhager, WH
Citation: Jis. Robertson et Wh. Birkenhager, Introduction: Controversies in the treatment of hypertension, CARDIO DRUG, 14(4), 2000, pp. 355-355

Authors: Gasowski, J Birkenhager, WH Staessen, JA de Leeuw, PW
Citation: J. Gasowski et al., Benefit of antihypertensive treatment in the diabetic patients enrolled inthe systolic hypertension in Europe (Syst-Eur) trial, CARDIO DRUG, 14(1), 2000, pp. 49-53

Authors: Staessen, JA Birkenhager, WH Fagard, RH
Citation: Ja. Staessen et al., Dihydropyridine calcium-channel blockers for the treatment of hypertensivediabetic patients, EUR HEART J, 21(1), 2000, pp. 2-7

Authors: Seux, ML Forette, F Staessen, JA Thijs, L Birkenhager, WH Webster, J Babarskiene, MR Babeanu, S Bossini, A Gil-Extremera, B Girerd, X Laks, T Lilov, E Moisseyev, V Tuomilehto, J Vanhanen, H Yodfat, Y Fagard, R
Citation: Ml. Seux et al., Treatment of isolated systolic hypertension and dementia prevention in older patients - Results of the Systolic Hypertension in Europe Trial (SYST-EUR) vascular dementia project, EUR H J SUP, 1(M), 1999, pp. M6-M12

Authors: Gasowski, J Staessen, JA Celis, H Fagard, RH Thijs, L Birkenhager, WH Bulpitt, CJ Fletcher, AE Arabidze, GG de Leeuw, P Dollery, CT Duggan, J Kawecka-Jaszcz, K Leonetti, G Nachev, C Safar, M Rodico, JL Rosenfeld, J Seux, ML Tuomilehto, J Webster, J Yodfat, Y
Citation: J. Gasowski et al., Systolic Hypertension in Europe (Syst-Eur) Trial Phase 2: objectives, protocol, and initial progress, J HUM HYPER, 13(2), 1999, pp. 135-145

Authors: Birkenhager, WH de Leeuw, PW
Citation: Wh. Birkenhager et Pw. De Leeuw, Non-peptide angiotensin type 1 receptor antagonists in the treatment of hypertension, J HYPERTENS, 17(7), 1999, pp. 873-881

Authors: Staessen, JA Wang, JG Birkenhager, WH Fagard, R
Citation: Ja. Staessen et al., Treatment with beta-blockers for the primary prevention of the cardiovascular complications of hypertension, EUR HEART J, 20(1), 1999, pp. 11-24

Authors: Staessen, JA Thijs, L Birkenhager, WH Bulpitt, CJ Fagard, R
Citation: Ja. Staessen et al., Update on the systolic hypertension in Europe (Syst-Eur) trial, HYPERTENSIO, 33(6), 1999, pp. 1476-1477

Authors: Forette, F Staessen, JA Thijs, L Birkenhager, WH
Citation: F. Forette et al., Prevention of dementia: Syst-Eur trial - Reply, LANCET, 353(9148), 1999, pp. 236-237

Authors: Tuomilehto, J Staessen, JA Birkenhager, WH
Citation: J. Tuomilehto et al., Calcium-channel blockade and hypertension - Reply, N ENG J MED, 341(5), 1999, pp. 373-373

Authors: Tuomilehto, J Rastenyte, D Birkenhager, WH Thijs, L Antikainen, R Bulpitt, CJ Fletcher, AE Forette, F Goldhaber, A Palatini, P Sarti, C Fagard, R Staessen, JA Arabidze, GG Carrageta, M Celis, H Kocemba, J Leonetti, G Nachev, C O'Brien, ET Ritz, E Rodicio, JL Rosenfeld, J Heyrman, J Stibbe, G Van den Haute, H Yodfat, Y De Cort, P Hubner, GE
Citation: J. Tuomilehto et al., Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension, N ENG J MED, 340(9), 1999, pp. 677-684
Risultati: 1-23 |